Literature DB >> 10695011

Gastroesophageal reflux disease in children.

S R Orenstein1, F Izadnia, S Khan.   

Abstract

In the pediatric population, gastroesophageal reflux most often presents in infancy as effortless regurgitation, but pathologic GERD is accompanied by signs of malnutrition, respiratory diseases, and esophagitis or its complications. Because of the distinctive pathophysiology predisposing infants to GERD, the diagnostic approach must begin with a thorough history that determines the extent of further diagnostic tests and the course of management. Empiric therapy assumes importance in infants with GERD because of the limited differential diagnoses in consideration. Conservative therapy is of utmost importance because of the unique provocative factors in the pathophysiology of infantile GERD. Prokinetic pharmacotherapy takes precedence over acid suppression because of the more important role of motility factors compared with acid secretion in infantile GERD.

Entities:  

Mesh:

Year:  1999        PMID: 10695011     DOI: 10.1016/s0889-8553(05)70099-6

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

Review 1.  Clinical implications of molecular changes in pediatric Barrett's esophagus.

Authors:  Licia Pensabene; Marta C Cohen; Michael Thomson
Journal:  Curr Gastroenterol Rep       Date:  2012-06

2.  "Shaken baby syndrome" and forensic pathology.

Authors:  Christopher Spencer Greeley
Journal:  Forensic Sci Med Pathol       Date:  2014-02-16       Impact factor: 2.007

3.  Postfundoplication Complications in Children.

Authors:  Susan R. Orenstein; Carlo Di Lorenzo
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

Review 4.  Lansoprazole: in the management of gastroesophageal reflux disease in children.

Authors:  Lesley J Scott
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

5.  Extrapolation of Efficacy in Pediatric Drug Development and Evidence-based Medicine: Progress and Lessons Learned.

Authors:  Haihao Sun; Jean W Temeck; Wiley Chambers; Ginger Perkins; Renan Bonnel; Dianne Murphy
Journal:  Ther Innov Regul Sci       Date:  2017-08-18       Impact factor: 1.778

6.  Low reproducibility of 2 x 24-hour continuous esophageal pH monitoring in infants and children: a limiting factor for interventional studies.

Authors:  Rasmus Gaardskaer Nielsen; Søren Kruse-Andersen; Steffen Husby
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

Review 7.  Comparative safety and efficacy of proton pump inhibitors in paediatric gastroesophageal reflux disease.

Authors:  Jaroslaw Kierkus; Grzegorz Oracz; Bartosz Korczowski; Edyta Szymanska; Anna Wiernicka; Marek Woynarowski
Journal:  Drug Saf       Date:  2014-05       Impact factor: 5.606

8.  Ethnicity and gender related differences in extended intraesophageal pH monitoring parameters in infants: a retrospective study.

Authors:  Dena Nazer; Ronald Thomas; Vasundhara Tolia
Journal:  BMC Pediatr       Date:  2005-07-18       Impact factor: 2.125

9.  Regurgitation in healthy and non healthy infants.

Authors:  Flavia Indrio; Giuseppe Riezzo; Francesco Raimondi; Luciano Cavallo; Ruggiero Francavilla
Journal:  Ital J Pediatr       Date:  2009-12-09       Impact factor: 2.638

Review 10.  Treatment of pediatric sinusitis.

Authors:  Ari J Goldsmith; Richard M Rosenfeld
Journal:  Pediatr Clin North Am       Date:  2003-04       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.